Open access · Peer reviewed · No APCs
Case ReportIndian Journal of Pharmaceutical Education and ResearchVol. 52 | Issue 3 | 2018 | pp. 540–542Open access
Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1α Treatment
- 1,2,
- 1,3,
- 1,3,
- 1,4*
- 1 Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, IRAN.
- 2 Department of Neurology, Isfahan University of Medical Sciences, Isfahan, IRAN.
- 3 Medical students’ research Committee, Isfahan University of Medical Sciences, Isfahan, IRAN.
- 4 Non-communicable Disease Unit, Vice Chancellor for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, IRAN.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Nafiseh Toghianifar
Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, IRAN.; Non-communicable Disease Unit, Vice Chancellor for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, IRAN.
Email: n.toghiani@gmail.com
Copyright: © 2018 Manuscript Technomedia. This is an open access article.
- Published:
- Jun 17, 2018
- Received:
- Sep 29, 2017
- Accepted:
- Dec 15, 2017
How to cite
Shaygannejad, V., Fayyazi, E., Mirmosayyeb, O., & Toghianifar, N. (2018). Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1α Treatment. Indian Journal of Pharmaceutical Education and Research, 52(3), 540–542. https://doi.org/10.5530/ijper.52.3.62
Abstract
Immune thrombocytopenia is an isolated thrombocytopenia not related to other etiologies of thrombocytopenia.1 The diagnosis relies mainly on exclusion of other conditions.2,3 The incidence of ITP among adults has been estimated to be 3.3 per 100,000 persons in Europe according to a review study in 2009.4 ITP may be induced by drugs.2 In this type of ITP, a drug induces production of antibodies against platelets and causes destruction and reduction of platelets.2 This is usually transient and improves after withdrawal of the offending drug.1,2
Subject
Article metadata
| Title | Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1α Treatment |
|---|---|
| Authors | Vahid Shaygannejad; Emad Fayyazi; Omid Mirmosayyeb; Nafiseh Toghianifar |
| Affiliations | Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, IRAN.; Department of Neurology, Isfahan University of Medical Sciences, Isfahan, IRAN.; Medical students’ research Committee, Isfahan University of Medical Sciences, Isfahan, IRAN.; Non-communicable Disease Unit, Vice Chancellor for Clinical Affairs, Isfahan University of Medical Sciences, Isfahan, IRAN. |
| Corresponding author | n.toghiani@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 52, Issue 3 (2018) |
Also in this issue
- Development of pH Independent Drug Release System for Dipyridamolepp. 374–380
- Enantioseparation of D- and L- isomers of Chiral Drugs for Improving their Bioavailability: Some Techniques Including Micellization with Gemini Surfactantspp. 334–341
- “Breaking Bad” Television Series Explained to Studentspp. 342–350
- Service Quality Gap Measurement in Pharmaceutical Educational Institutes: An Empirical Analysis for Model Developmentpp. 351–362
- Carboxymethyl Tamarind Seed Kernel Polysaccharide Formulated into Pellets to Target at Colonpp. 363–373
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026